|
Stocks That Stand Out For Nov. 23rd, 2009 Are MRNJ, INAR, CCTR, LPIH, NNVC
(M2 PressWIRE Via Acquire Media NewsEdge) www.Standoutstocks.com: Stocks That Standout For Nov. 23rd, 2009 are Metatron, Inc. (PINKSHEETS: MRNJ), InternetArray, Inc. (PINKSHEETS: INAR), China Crescent Enterprises, Inc. (OTCBB: CCTR), Longwei Petroleum Investment Holding Ltd. (OTC Bulletin Board: LPIH), NanoViricides, Inc. (OTCBB: NNVC) Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com _________________________________________________
Metatron Acquires PB Magic Inc.
Creative and Technical Backbone of Future Growth Acquired in All Stock Transaction
SAN DIEGO, CA, Nov 23, 2009 -- Metatron, Inc. (PINKSHEETS: MRNJ) is pleased to announce that it has completed the acquisition of PB Magic, Inc. for five million shares of its restricted common stock valued at $0.15 per share.
Founded in 2000, PB Magic provides web hosting, design, development, custom programming, database integration, and PPC/SEC advertising campaign management to Fortune 500, public sector and small business clientele. The firm has been engaged by hundreds of high profile clients throughout its history including Boeing, Scudder Investments, ADM, and Yum! Brands (Kentucky Fried Chicken), and has averaged approximately $1.5 million in profitable revenue per year since inception.
Metatron CEO Joe Riehl said, "PB Magic delivers a unique combination of application management and implementation, hosting and content delivery services to provide full cycle support for today's industry leaders. Apart from their own operations, we see PB Magic as the technological backbone and creative engine for everything we do. This is a key acquisition that helps us set the table for the future." About PB Magic Inc.
PB Magic provides outsourced enterprise applications and related technology services to drive efficiency and effectiveness in information technology operations for all sized companies. Our experience and proven expertise in vertical markets like publishing, media, entertainment, financial services, software and public sector creates success for our clientele.
About Metatron Inc.
Metatron Inc. is a diversified internet holding company with a mission to harness the power of today's online and wireless consumer interactivity to make daily life easier, more productive and more entertaining for people all over the world. For more information on the Company, please visit www.metatroninc.com.
Forward-Looking Statements Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company's operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement.
InternetArray to Give Online Investor Presentation
Will Address Submitted Investor Questions
NEW YORK, NY, Nov 20, 2009 -- InternetArray, Inc. (PINKSHEETS: INAR) will provide a review of 2009 and an update on company strategy including long-term focus in an online investor presentation on December 3rd, 2009. The company will include responses to collated topics from questions submitted by investors prior to presentation.
"InternetArray has accomplished a lot this year and we have more projects planned for 2010," said Michael Black, CEO of Internet Array. "We're continually building value in the Company and those we incubate. We look forward to letting our shareholders know more about our plans, responding to as many of their questions as possible, and getting them as excited as we are about the future of InternetArray and its properties." Investors may submit their questions by visiting the Company Facebook page at http://www.facebook.com/InternetArray or emailing 2009@InternetArray.com on or before November 30th, 2009.
About InternetArray, Inc. (www.internetarray.com) InternetArray, Inc. provides guidance and investment for innovative, early stage Internet companies. The Company's mission is to identify and develop collaborative business partners into viable and profitable companies.
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
China Crescent Enterprises, Inc. Releases 3rd Quarter Financial Report First Look Webcast to Review Record Net Income, Earnings per Share, and Suggested Fair Value Target Price per Share
DALLAS, TX, Nov 20, 2009 -- China Crescent Enterprises, Inc. (OTCBB: CCTR) has released a first look, on-demand Webcast to review the recently filed third quarter 2009 financial results on SEC Form 10-Q.
The Company reported $30 million in revenue through the nine months ending September 30, 2009 and a record net income of $1.8 million compared to $517k in net income for the same period in 2008. The Company has forecasted profitable revenue growth in 2009 compared to 2008. The Company reported over $40 million in profitable revenue in 2008.
Today's Webcast is an initial review of the 3rd quarter results to include a review of record net income, earnings per share, and the suggested fair value target price per share, with further review scheduled to be released on Monday. A link to the on-demand Webcast is now available on the corporate website homepage www.chinacrescent.com titled 'China Crescent 3rd Quarter First Look Webcast'.
Sign Up to Receive Regular China Crescent Investor Updates China Crescent sends regular email updates to its opt-in, permission-based email database. Interested investors can easily, safely and quickly register to receive these communications directly on the corporate website homepage (www.chinacrescent.com). Recipients can manage their own email contact profile and safely unsubscribe at any time.
About China Crescent Enterprises, Inc. (www.chinacrescent.com) China Crescent Enterprises, Inc. reported over $40 million in profitable revenue in 2008. The Company is a technology leader in the rapidly developing Chinese market specializing today in software engineering, high quality software development and digital multimedia outsourcing services delivered to customers globally. At the same time, the firm is a systems integrator and value added reseller of major global hardware brands in the Chinese domestic market.
Headquartered in Dallas with operations in Shanghai and Beijing, China Crescent bridges the gap between Western and Eastern business cultures to assist Western clients in realizing the advantages of the high quality, low cost technology products and services available from China. China Crescent also assists Western clients in localizing products and services to realize the tremendous growth potential available by expanding into the Chinese Market.
"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause China Crescent's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.
Longwei Petroleum Announces Revenue and Earnings for the First Quarter of Fiscal Year 2010 Ended September 30, 2009
TAIYUAN CITY, China, Nov 20, 2009 --
-- Revenue up 33% Year-over-Year to $59.36 million -- Net Income up 31% Year-over-Year to $7.21 million, or $0.09 EPS -- Net Income Excluding Non-Cash Fair Value Adjustments Associated with Stock Warrants was $8.26 million, or $0.10 EPS -- Operating Income up 48% Year-over-Year to $11.06 million
Longwei Petroleum Investment Holding Ltd. (OTC Bulletin Board: LPIH) announced its financial results for the quarterly period ended September 30, 2009.
Mr. Cai Yongjun, chairman and chief executive officer of Longwei Petroleum Investment Holding Ltd., stated: "I am very pleased with our financial results for the first quarter of fiscal 2010. I can also say that plans to have our Gujiao facility fully operational in January 2010 are on track, and the facility is already fulfilling some small but daily customer orders for us at this time. We look forward to strong growth in both Taiyuan and Gujiao during the next several years to come." The Company reported revenue of $59.36 million for the three-month period ended September 30, 2009, up 33% from $44.48 million for the same three-month period of 2008. The increase was primarily due to certain new customer contracts. The Company continued to expand its customer base, and the pricing of its products continued to follow a trend toward higher, more profitable pricing. The average sales price per metric ton of product the Company sold was $1,142 and $1,014 during the three months ended September 30, 2009 and 2008, respectively.
Costs of sales for the three months ended September 30, 2009 were $47.75 million as compared to $34.84 million for the three months ended September 30, 2008. The increase of $12.92 million, or 37%, was primarily due to the revenue growth resulting from certain new customer contracts. Gross profit was 20% and 22%, respectively, for the three months ended September 30, 2009 and 2008. The average cost basis per metric ton of product the Company sold was $913 and $780 during the three months ended September 30, 2009 and 2008, respectively.
Operating expenses for the three months ended September 30, 2009 amounted to $545,000 as compared to $2.17 million for the three months ended September 30, 2008. The decrease of $1.62 million, or 75%, was primarily due to the curtailing of administrative costs in order to focus resources on the new Gujiao facility's buildout.
Net income grew 31% year-over-year to $7.21 million, or earnings per share of $0.09, up from earnings per share of $0.07 in 2008. Operating income was $11.06 million compared to $7.47 million for 2008, which represents growth of 48% year-over-year.
Chief Financial Officer Jim Crane stated: "We exceeded our internal forecasts for the quarterly reporting period ended September 30, 2009. Revenues were approximately $5.6 million higher than expected due to significant additional sales in August and September, while net income was approximately $600,000 higher than expected. The new facility looks very good and is already active. We are the only licensed non-government operated fuel distributor in Gujiao who also has significant storage capacity. As previously announced, we expect very strong growth in fiscal 2010." Financial Outlook: As of September 30, 2009, the Company's current assets were $85.24 million and current liabilities were $7.91 million. Cash and cash equivalents totaled $9.43 million as of September 30, 2009. The Company's shareholders' equity at September 30, 2009 was $121.65 million compared to $114.92 million at June 30, 2009. The Company had cash provided by operating activities for the three months ended September 30, 2009 of $9.57 million compared to cash used in operating activities of $751,000 for the three months ended September 30, 2008. Net cash used in investing activities was $7.64 million for the three months ended September 30, 2009 compared to $0 for the three months ended September 30, 2008. The Company had net cash provided by financing activities of $76,000 for the three months ended September 30, 2009 compared to $0 for the three months ended September 30, 2008.
About Longwei Petroleum Investment Holding Limited Longwei Petroleum Investment Holding, Limited (the "Company") is an energy company that, through its subsidiaries, engages in oil and gas operations in the People's Republic of China ("PRC"). Oil and gas operations consist of transporting, marketing and selling finished petroleum products. The Company's headquarters and primary facilities are located in Taiyuan City, Shanxi Province ("Shanxi"). The Company's second facility is located in Gujiao, Shanxi. The Company purchases diesel, gasoline, fuel oil and kerosene (the "Products") from various petroleum refineries in the PRC. The Company is 1 of 3 licensed intermediaries in Taiyuan City and the sole licensed intermediary in Gujiao that operates its own large scale storage tanks. The Company has the necessary licenses to operate and sell Products not only in Shanxi but throughout the entire PRC. The Company's storage tanks have the largest storage capacity of any privately operated entity in Shanxi. The Company seeks to earn profits by selling its Products at competitive prices to large-scale gas stations, coal plants, other power-supply customers and small, independent gas stations. The Company also earns revenue by acting as a purchasing agent for other intermediaries in Shanxi and through the sale of diesel and gasoline at gas stations located at each of the Company's facilities. The sales price and the cost basis of the Company's products are largely dependent on the price of crude oil. The price of crude oil is subject to fluctuation due to a variety of factors, all of which are beyond the Company's control. For further information on Longwei Petroleum Investment Holding Limited, please visit http://www.longweipetroleum.com . You may register to receive Longwei Petroleum Investment Holding Limited's future press releases or request to be added to the Company's distribution list by contacting Dave Gentry at info@RedChip.com or 1-800-733-2447, Ext. 104.
Forward-Looking Statements Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates and projections about Longwei's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Longwei's operations are conducted in the PRC and, accordingly, are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company's results may be adversely affected by changes in the political and social conditions in the PRC and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation. Other potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. Readers should review carefully reports or documents the Company files periodically with the Securities and Exchange Commission.
NanoViricides Presents FluCide(TM) Animal Study Data at Influenza Congress - Now Improved Substantially and Vastly Superior to Current Treatment
WEST HAVEN, Conn., Nov 23, 2009 -- NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide(TM) animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC (www.terrapinn.com/usaflu). These data clearly established that the new version of FluCide(TM) is superior to the older version. The data also showed extremely large survival lifetime improvement compared to an extended therapy using oseltamivir (Tamiflu(R) Roche).
Separately, Dr. Anil R. Diwan, President of the Company, presented a talk on November 18th at the Nano and Clean Tech 2009 Conference (http://www.chemshow.com/includes/nano.pdf) in New York City, held in conjunction and partnership with the Chem Show 2009 (http://www.chemshow.com).
Dr. Diwan gave a description of the nanomedicine technology on which the Company's product platform is based. He then went on to discuss the successful development of several drug candidates in a relatively short timeframe and with very small R&D expenditures that NanoViricides Inc. has been able to achieve. "Our achievements have clearly demonstrated that we can develop drug candidates against new virus targets very quickly," he said. He explained that the multi-point binding of a nanoviricide(TM), enabled by the underlying TheraCour(R) polymer, results in a nanoscale "velcro" or zipper-like effect. This allows the Company to employ virus-binding ligands with relatively low affinities successfully. "Other drug development approaches require discovery of antibodies or chemicals with very high affinities, sub-micromolar or better, which takes a lot of time and money," he said, adding, "In contrast, our technology allows us to use mimics of the natural and conserved binding sites of the viruses. This allows rapid development. Also, it means that a virus is far less likely to escape a nanoviricide compared to its escape rate against a highly specific drug discovered using a conventional methodology." The recent animal study of FluCide was conducted using the same total lethality protocol employed in previous influenza studies by the Company. The new version of FluCide drug candidate extended the lifespan of lethally infected mice to 334?11 hrs (or 14 days) on average. In contrast, mice treated with an extended oseltamivir protocol survived for 193?3 hrs (or 8 days) on average. Control infected mice survived for only 121?2 hrs (or 5 days). FluCide was given as an IV injection, on alternate days, for five treatments. Oseltamivir was given as oral, twice daily, each at 20mg/kg through life (or 14 treatments). Previously, oseltamivir given using the customary protocol of oral, twice daily, each at 20mg/kg for 4 days (8 treatments), has produced a survival time of 151?1 hrs (or 6.3 days) in this model. Several additional parameters have been evaluated in this study. The Company expects to analyze the data from these additional parameters as they are received in the near future.
The Company believes that the lifetime data demonstrate an unquestionable superiority of the FluCide drug candidate compared to current drugs, and establish it as a viable therapy against influenza. We believe that FluCide is likely the most effective drug candidate in development against influenza, based on these results.
The studies were conducted by Dr. Krishna Menon, PhD, VMD, MRCS, at KARD Scientific, MA. One million virus particles of Influenza A Strain A/WS/33 (H1N1) were aspirated directly into the lungs of mice. A repeat "booster" infection was performed at 22 hrs. This is a highly lethal model, allowing the survival lifetimes to be directly used for rank ordering of efficacy of drug candidates.
The Company has previously shown that a previous version of the FluCide drug candidate was highly effective against two different clades of the H5N1 bird flu virus, in addition to being highly effective against H1N1 in the mouse model. The Company has recently improved the FluCide drug candidate, creating what it believes to be a single drug candidate against all forms of influenza. The Company believes that the data we presented at the Influenza Conference establish this pan-influenza drug candidate as a leading anti-influenza drug in development.
About NanoViricides: NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide(TM) class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others.
This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in pre-clinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.
About Standoutstocks.com www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.
www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button.
Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ InfoTech Spotlight's Homepage ]
|
